Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
American Journal of Public Health ; 112:S478-S483, 2022.
Article in English | ProQuest Central | ID: covidwho-2047025
2.
IOP Conference Series. Earth and Environmental Science ; 1063(1):012034, 2022.
Article in English | ProQuest Central | ID: covidwho-1984999
3.
American Journal of Public Health ; 112(5):716-718, 2022.
Article in English | ProQuest Central | ID: covidwho-1842794
4.
Water Res ; 218: 118481, 2022 Jun 30.
Article in English | MEDLINE | ID: covidwho-1796028

ABSTRACT

Monitoring SARS-CoV-2 RNA in sewer systems, upstream of a wastewater treatment plant, is an effective approach for understanding potential COVID-19 transmission in communities with higher spatial resolutions. Passive sampling devices provide a practical solution for frequent sampling within sewer networks where the use of autosamplers is not feasible. Currently, the design of upstream sampling is impeded by limited understanding of the fate of SARS-CoV-2 RNA in sewers and the sensitivity of passive samplers for the number of infected individuals in a catchment. In this study, passive samplers containing electronegative membranes were applied for at least 24-h continuous sampling in sewer systems. When monitoring SARS-CoV-2 along a trunk sewer pipe, we found RNA signals decreased proportionally to increasing dilutions, with non-detects occurring at the end of pipe. The passive sampling membranes were able to detect SARS-CoV-2 shed by >2 COVID-19 infection cases in 10,000 people. Moreover, upstream monitoring in multiple sewersheds using passive samplers identified the emergence of SARS-CoV-2 in wastewater one week ahead of clinical reporting and reflected the spatiotemporal spread of a COVID-19 cluster within a city. This study provides important information to guide the development of wastewater surveillance strategies at catchment and subcatchment levels using different sampling techniques.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , RNA, Viral , Wastewater , Wastewater-Based Epidemiological Monitoring
5.
Immunogenetics ; 74(5): 455-463, 2022 10.
Article in English | MEDLINE | ID: covidwho-1750684

ABSTRACT

G-quadruplex structure or Putative Quadruplex Sequences (PQSs) are abundant in human, microbial, DNA, or RNA viral genomes. These sequences in RNA viral genome play critical roles in integration into human genome as LTR (Long Terminal Repeat), genome replication, chromatin rearrangements, gene regulation, antigen variation (Av), and virulence. Here, we investigated whether the genome of SARS-CoV2, an RNA virus, contained such potential G-quadruplex structures. Using bioinformatic tools, we searched for such sequences and found thirty-seven (forward strand (twenty-five) + reverse strand (Twelve)) QGRSs (Quadruplex forming G-Rich Sequences)/PQSs in SARS-CoV2 genome. These sequences are dispersed mainly in the upstream of SARS-CoV2 genes. We discuss whether existing PQS/QGRS ligands could inhibit the SARS-CoV2 replication and gene transcription as has been observed in other RNA viruses. Further experimental validation would determine the role of these G-quadruplex sequences in SARS-CoV2 genome function to survive in the host cells and identify therapeutic agents to destabilize these PQSs/QGRSs.


Subject(s)
COVID-19 , G-Quadruplexes , COVID-19/genetics , DNA , Humans , RNA, Viral/chemistry , RNA, Viral/genetics , SARS-CoV-2/genetics
6.
Energies ; 15(5):1750, 2022.
Article in English | ProQuest Central | ID: covidwho-1736864
7.
2nd International Conference on Advanced Research in Mechanical Engineering-2021, ICARME 2021 ; 2421, 2022.
Article in English | Scopus | ID: covidwho-1684228
8.
Sci Total Environ ; 821: 153250, 2022 May 15.
Article in English | MEDLINE | ID: covidwho-1631648

ABSTRACT

Sewage surveillance could help develop proactive response to the Coronavirus Disease 2019 (COVID-19) pandemic, but currently there are limited reports about examples in practical exercises. Here, we report a use case of intensified sewage surveillance to initiate public health action to thwart a looming Delta variant outbreak in Hong Kong. On 21 June 2021, albeit under basically contained COVID-19 situation in Hong Kong, routine sewage surveillance identified a high viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a sewage sample from one site covering over 33,000 population, suggesting infected cases living in the respective sewershed. The use of a newly developed method based on allele-specific real-time quantitative polymerase chain reaction (AS RT-qPCR) served to alert the first documentation of the Delta variant in local community sewage three days before the case was confirmed to be a Delta variant carrier. Intensified sewage surveillance was triggered. Targeted upstream sampling at sub-sewershed areas pinpointed the source of positive viral signal across spatial scales from sewershed to building level, and assisted in determining the specific area for issuing a compulsory testing order for individuals on 23 June 2021. A person who lived in a building with the positive result of sewage testing was confirmed to be infected with COVID-19 on 24 June 2021. Viral genome sequences determined from the sewage sample were compared to those from the clinic specimens of the matched patient, and confirmed that the person was the source of the positive SARS-CoV-2 signal in the sewage sample. This study could help build confidences for public health agencies in using the sewage surveillance in their own communities.


Subject(s)
COVID-19 , COVID-19/epidemiology , Hong Kong/epidemiology , Humans , Public Health , SARS-CoV-2/genetics , Sewage
9.
International Journal of Environmental Sustainability and Green Technologies ; 13(1):1-5, 2022.
Article in English | ProQuest Central | ID: covidwho-1614077
10.
"19th LACCEI International Multi-Conference for Engineering, Education Caribbean Conference for Engineering and Technology: """"Prospective and Trends in Technology and Skills for Sustainable Social Development"""" and """"Leveraging Emerging Technologies to Construct the Future"""", LACCEI 2021" ; 2021-July, 2021.
Article in Spanish | Scopus | ID: covidwho-1609078
11.
Biotechnol Bioeng ; 118(10): 3996-4013, 2021 10.
Article in English | MEDLINE | ID: covidwho-1293144

ABSTRACT

Seasonal influenza epidemics occur both in northern and southern hemispheres every year. Despite the differences in influenza virus surface antigens and virulence of seasonal subtypes, manufacturers are well-adapted to respond to this periodical vaccine demand. Due to decades of influenza virus research, the development of new influenza vaccines is relatively straight forward. In similarity with the ongoing coronavirus disease 2019 pandemic, vaccine manufacturing is a major bottleneck for a rapid supply of the billions of doses required worldwide. In particular, egg-based vaccine production would be difficult to schedule and shortages of other egg-based vaccines with high demands also have to be anticipated. Cell culture-based production systems enable the manufacturing of large amounts of vaccines within a short time frame and expand significantly our options to respond to pandemics and emerging viral diseases. In this study, we present an integrated process for the production of inactivated influenza A virus vaccines based on a Madin-Darby Canine Kidney (MDCK) suspension cell line cultivated in a chemically defined medium. Very high titers of 3.6 log10 (HAU/100 µl) were achieved using fast-growing MDCK cells at concentrations up to 9.5 × 106 cells/ml infected with influenza A/PR/8/34 H1N1 virus in 1 L stirred tank bioreactors. A combination of membrane-based steric-exclusion chromatography followed by pseudo-affinity chromatography with a sulfated cellulose membrane adsorber enabled full recovery for the virus capture step and up to 80% recovery for the virus polishing step. Purified virus particles showed a homogenous size distribution with a mean diameter of 80 nm. Based on a monovalent dose of 15 µg hemagglutinin (single-radial immunodiffusion assay), the level of total protein and host cell DNA was 58 µg and 10 ng, respectively. Furthermore, all process steps can be fully scaled up to industrial quantities for commercial manufacturing of either seasonal or pandemic influenza virus vaccines. Fast production of up to 300 vaccine doses per liter within 4-5 days makes this process competitive not only to other cell-based processes but to egg-based processes as well.


Subject(s)
COVID-19 , Cell Culture Techniques , Influenza A Virus, H1N1 Subtype/growth & development , Influenza Vaccines/metabolism , SARS-CoV-2/growth & development , Animals , Dogs , Madin Darby Canine Kidney Cells
12.
Int J Health Serv ; 51(1): 55-58, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-694786

ABSTRACT

The upstream causes of the COVID-19 pandemic have received little attention so far in public health and clinical medicine, as opposed to the downstream effects of mass morbidity and mortality. To resolve this pandemic and to prevent even more severe future pandemics, a focus on upstream causation is essential. Convincing evidence shows that this and every other important viral epidemic emerging in the recent past and predictably into the future comes from the same upstream causes: capitalist agriculture, its destruction of natural habitat, and the industrial production of meat. International and national health organizations have obscured the upstream causes of emerging viral epidemics. These organizations have suffered cutbacks in public funding but have received increased support from international financial institutions and private philanthropies that emphasize the downstream effects rather than upstream causes of infectious diseases. Conflicts of interest also have impacted public health policies. A worldwide shift has begun toward peasant agricultural practices: Research so far has shown that peasant agriculture is safer and more efficient than capitalist industrial agricultural practices. Without such a transformation of agriculture, even more devastating pandemics will result from the same upstream causes.


Subject(s)
COVID-19/epidemiology , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/virology , Pandemics , Agriculture , Animals , Capitalism , Ecosystem , Extinction, Biological , Food-Processing Industry , Humans , Meat , Risk Factors , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL